articleTop 10% cited
Expression of Prostate‐Specific Membrane Antigen in Normal and Malignant Human Tissues
World Journal of Surgery · 2006 · Vol. 30(4) · pp. 628–636
Yoshihisa Kinoshita✉(Osaka City University)Katsuyuki Kuratsukuri(Osaka City University)Steve Landas(SUNY Upstate Medical University)Katsumi Imaida(Kagawa University)Peter M. Rovito(SUNY Upstate Medical University)Ching Y. Wang(SUNY Upstate Medical University)Gabriel P. Haas(SUNY Upstate Medical University)
Abstract
These findings demonstrate that PSMA is widely distributed in normal tissues, and, depending on the tumors, its expression is up- or down-regulated, or unchanged. The broad distribution of PSMA may make it suitable for the diagnosis and therapy of a wide variety of tumors.
Prostate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsImmunotherapy and Immune ResponsesProstatePathologyMedicineImmunohistochemistryLungUrinary bladderProstate cancerAdenocarcinomaPCA3Cancer
MeSH terms
Antigens, SurfaceFemaleHumansMaleNeoplasmsProstateProstatic NeoplasmsReference ValuesTissue DistributionTumor Cells, CulturedBiomarkers, TumorGlutamate Carboxypeptidase II
Funding
- National Institutes of Health
Citations
375
FWCI
7.56
field-weighted impact
References
41
Percentile
97%
vs. same field & year
Citations per year
Cited by
PD-1– and CTLA-4–Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses
Science Translational Medicine · 2013 · 714 citations
References
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases
Urology · 1998 · 598 citations
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
Journal of Cellular Biochemistry · 2003 · 867 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.